Healio – Oct. 10
Michael Jain, MD, PhD, FRCPC, an assistant member for blood and marrow transplantation and cellular immunotherapy at Moffitt Cancer Center agrees with Tombaro that both studies are similar yet use slightly different experimental designs. In the end, however, in tandem they show that dasatinib can be used to shut off CAR T-cell function and after a drug wash-out period, recover function.
Renal and Urology News – Oct. 10
Kosj Yamoah, MD, PhD, Section Chief of Genitourinary Radiation Oncology, and Director of Radiation Oncology Disparities Research at the Moffitt Cancer Center in Tampa, Florida, said the study is important because it confirms similar findings but in a more modern cohort.
GenomeWeb – Oct. 10
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
DocWire – Oct. 9
According to a press release distributed by Moffitt Cancer Center, researchers have uncovered differences at the single-cell level of melanoma that can predict responses to initial targeted BRAF inhibitor treatments. Their findings were published in EBioMedicine.
Sun Newspapers – Oct. 10
“I was given the option of having a mastectomy or trying to find the breast cancer. “I ended up going to Moffitt in Tampa.”
Genetic Engineering & Biotechnology News – Oct. 9
A new study from investigators at the Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have just released findings from a new study revealing that differences at the single-cell level can predict responses to initial BRAF inhibitor therapy and that leveraging these differences may improve patient outcomes.
Sunday Dispatch – Oct. 9
All proceeds from the event go directly to cancer research at The University of Pennsylvania and the Moffitt Cancer Center in Tampa, Florida.
Daily Mail – Oct. 8
'The virus genetically hijacks the cancer cell and multiples, and so many copies are produced that [the cell] ruptures,' Dr Amod Sarnaik, a surgical oncologist at Moffitt Cancer Center in Florida, who did not treat Tripoli, told DailyMail.com
Bay News 9
Melissa Eichman sat down with a Moffitt Cancer Center genetic counselor Christine Steele to help us learn about your genetics and your medical history
Newswise – Oct. 8
In a new study published in EBioMedicine, researchers with Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence reveal that differences at the single-cell level can predict responses to initial BRAF inhibitor therapy, and that leveraging these differences may improve patient outcomes.
News Medical – Oct. 8
In a new study published in EBioMedicine, researchers with Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence reveal that differences at the single-cell level can predict responses to initial BRAF inhibitor therapy, and that leveraging these differences may improve patient outcomes.
NCI – Oct. 8
“We are hoping that if we show efficacy of the vaccine, that vaccinating both males and females will ultimately reverse” the rising incidence of HPV-related oropharyngeal cancers, said one of the trial’s lead investigators, Anna Giuliano, Ph.D., of Moffitt Cancer Center.
PR Newswire – Oct. 8
Additionally, the hospital has partnered with Moffitt Cancer Center to provide additional outpatient cancer services to patients needing treatment.
Florida Trend – Oct. 8
She has taken numerous mission trips to rural Honduras, is Chair of the Hospital Board of H. Lee Moffitt Cancer Center and Research Institute, and was prior Board President for Great Explorations, the Houghton-Wagman Children's Museum.
Florida Politics – Oct. 8
Houghton also serves as chair of the Hospital Board of H. Lee Moffitt Cancer Center and Research Institute. She previously served as board president for Great Explorations and the Houghton-Wagman Children’s Museum.
Accesswire.com – Oct. 7
In addition, the company announced that Roswell Park Comprehensive Cancer Center and Moffitt Cancer Center received approximately $15 million total in U.S. Department of Defense "Breakthrough Awards" to fund two separate but parallel clinical trials to study Ampligen as a potential synergistic agent in combination with several other immunotherapies - including pembrolizumab and Intron A - in the treatment of brain-metastatic breast cancer at Roswell and Moffitt.
WTSP – Oct. 4
Hillsborough County middle school students put on surgical gowns as part of their learning experience at Moffitt Cancer Center.
Business Observer – Oct. 4
Pasco County leaders believe they might have their coveted victory, with the mid-September announcement that the centerpiece of a proposed 800-acre mixed-used and corporate business park will be an H. Lee Moffitt Cancer facility.
Cancer Letter – Oct. 4
Moffitt Cancer Center has formed a contract research organization to accelerate the institution’s immunotherapy research.
Osprey Observer – Oct. 4
Along with online purchases, Pink Lift is set to become a preferred vendor with Moffitt Cancer Center.
Trial Site News – Oct. 5
The nation’s first Immuno-oncology-focused Contract research organizations (CRO) was launched in Florida as Moffitt Cancer Center announced today that they launched a first-of-its-kind CRO focused on accelerating immunotherapy research.
Citizens Voice – Oct. 6
“We’re an all-volunteer organization and 100% of our proceeds go to cancer research at the University of Pennsylvania, Philadelphia, and the H. Lee Moffitt Cancer Center in Tampa, Florida,” Sciandra said.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.